Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 32 n° 220

The smart choice in early-stage clinical research

Posted by fidest press agency su sabato, 19 ottobre 2019

To mark the opening of the Clinical Trials Phase I and Phase IIA Summit today in Philadelphia, the non-profit partnership CATALIS Québec has announced a promotional campaign to showcase the advantages of conducting early-stage clinical research in Quebec.In the coming weeks, The Smart Choice will present 10 physician-scientists and nine world-renowned research hospitals, with an eye to fostering university-industry collaboration in this cutting-edge sector.
Phase I and II trials are the first studies conducted on humans to provide scientific proof of the safety and efficacy of an experimental drug or a new therapeutic approach. This research often represents an opportunity to find an additional treatment for patients with serious diseases when standard therapies have failed.The pharmaceutical companies and contract research organizations that collaborate with Quebec’s university research centres to conduct their clinical trials benefit from an ecosystem geared towards operational excellence.“To continue to be a global leader in early-phase clinical trials, CATALIS Québec coordinates the efforts of several public and private partners in developing resources and tools and in helping to standardize ethical and contractual processes, to ensure that, for all industry players, Quebec remains the smart choice,” concluded Danika Laberge.


Inserisci i tuoi dati qui sotto o clicca su un'icona per effettuare l'accesso:

Logo di

Stai commentando usando il tuo account Chiudi sessione /  Modifica )

Google photo

Stai commentando usando il tuo account Google. Chiudi sessione /  Modifica )

Foto Twitter

Stai commentando usando il tuo account Twitter. Chiudi sessione /  Modifica )

Foto di Facebook

Stai commentando usando il tuo account Facebook. Chiudi sessione /  Modifica )

Connessione a %s...

%d blogger hanno fatto clic su Mi Piace per questo: